I'm most certainly not advocating the dissemination of any sensitive information that has not been outlined or regulated by the FDA such as patient information. If you don't understand the dynamics behind a well crafted PR, good luck to you Jumpin.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.